Dr. Reddys Laboratories Ltd.
BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1305.00
2.00
(0.15%)
< Home
< Back
Dr. Reddys Laboratories Ltd. News
>>
Dr. Reddy’s issues voluntary nationwide recall of Sapropterin Dihydrochloride Powder for Oral Solution
>>
Dr.Reddy's Laboratories submits certificate
>>
Dr. Reddy’s Laboratories’ arm to sell entire stake in Dr. Reddy’s Venezuela C.A., Venezuela
>>
Dr. Reddy’s launches drug-free migraine management wearable device Nerivio in Germany
>>
Dr. Reddy's, Bayer sign marketing, distribution agreement for second brand of Vericiguat in India
>>
Dr. Reddy's Laboratories rises on entering into exclusive partnership with Sanofi Healthcare India
>>
Dr. Reddy's Laboratories enters into exclusive partnership with Sanofi Healthcare India
>>
Dr. Reddy's Laboratories enters into license agreement with Pharmazz
>>
Dr. Reddy’s Laboratories launches Versavo in United Kingdom
>>
DR Reddy's Laboratories informs about press release
<<
<
17
18
19
...145
>
>>